MedTrace Logo

Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.

NCT00184353 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2011-10-21

No results posted yet for this study

Summary

Increasing magnetic field is known to give improvements in signal-to-noise-ratio (SNR) and spectral resolution. To investigate this, spectra from different subjects were examined using two clinical MR instruments operating at 1.5T and 3T respectively.

Conditions

  • Neoplasm Metastases

Sponsors & Collaborators

  • The Royal Norwegian Ministry of Health

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Steinar Lundgren, MD PhD · Cancer Clinic, St.Olavs Hospital Trondheim University Hospital

  • Ingrid S Gribbestad, PhD · Norwegian University of Science and Technology, Faculty of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-11-30
Primary Completion
2004-12-31
Completion
2005-06-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00184353 on ClinicalTrials.gov